Cantor Fitzgerald Reiterates Overweight on Progyny, Maintains $37 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Progyny (NASDAQ:PGNY) and maintained a $37 price target.
August 20, 2024 | 2:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald's analyst Sarah James has reiterated an Overweight rating on Progyny, maintaining a $37 price target, indicating confidence in the company's potential for growth.
The reiteration of an Overweight rating and maintenance of a $37 price target by a reputable analyst suggests a positive outlook for Progyny. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100